Clinical Drug Experience Knowledgebase

Carcinoma (Phase 1)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Colorectal Neoplasms (Phase 1)

Graft vs Host Disease (Phase 2)

Head and Neck Neoplasms (Phase 1)

Hodgkin Disease (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 2)

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 1)

Metabolic Diseases (Phase 1)

Microsatellite Instability (Phase 1)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Pancreatic Neoplasms (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Small Cell Lung Carcinoma (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Stomach Neoplasms (Phase 1)